Wynzora
- Product NDC
- 73499-001
- 11-digit product format
- 734990001
- Labeler code
- 73499
- Product ID
- 73499-001_22617d3b-9736-472b-bc08-1ce53fe151aa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Calcipotriene and Betamethasone dipropionate
- Dosage form
- CREAM
- Route
- TOPICAL
- Labeler
- MC2 Therapeutics Ltd
- Application
- NDA213422
- Marketing category
- NDA
- Marketing start
- 2021-06-30
- Substance
- BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
- Active strength
- 64; 50 mg/g; ug/g
- Pharmacologic classes
- Corticosteroid Hormone Receptor Agonists [MoA], Corticosteroid [EPC], Vitamin D Analog [EPC], Vitamin D [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Wynzora
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| BETAMETHASONE DIPROPIONATE | 64 mg/g |
| CALCIPOTRIENE | 50 ug/g |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 826Y60901U, 143NQ3779B |
| Rxcui | 2471873, 2471878 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 73499-001 | WYNZORA (CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE) CREAM [MC2 THERAPEUTICS LTD] | 6 | Current NDC, Legacy NDC, 4 package rows | 20231207_36c5c818-0d40-445e-a3c0-0f46723a25e2.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 73499-001-01 | 73499000101 | 1 TUBE in 1 CARTON (73499-001-01) / 60 g in 1 TUBE | 1 tube | 2021-06-30 | 0000-00-00 | No | No | Current |
| 73499-001-03 | 73499000103 | 10 TUBE in 1 CARTON (73499-001-03) / 5 g in 1 TUBE | 10 tube | 2021-06-30 | 0000-00-00 | Yes | No | Current |